Drug-Induced Parkinsonism

Journal of Clinical Neurology (Korea - Tập 8 Số 1 - Trang 15 - 2012
Hae‐Won Shin1, Sun Ju Chung2
1Department of Neurology, Chung-Ang University College of Medicine, Seoul, Korea
2Parkinson/Alzheimer Center, Department of Neurology, University of Ulsan College of Medicine, Seoul, Korea.

Tóm tắt

Từ khóa


Tài liệu tham khảo

Miller, 1990, South Med J, 83, 525, 10.1097/00007611-199005000-00011

Montastruc, 1994, Fundam Clin Pharmacol, 8, 293, 10.1111/j.1472-8206.1994.tb00808.x

Sethi, 2001, Semin Neurol, 21, 59, 10.1055/s-2001-13120

Esper, 2008, Mov Disord, 23, 401, 10.1002/mds.21854

Kägi, 2010, J Neurol Neurosurg Psychiatry, 81, 5, 10.1136/jnnp.2008.157370

Scherfler, 2007, Mov Disord, 22, 1229, 10.1002/mds.21505

Hall, 1956, J Am Med Assoc, 161, 214, 10.1001/jama.1956.02970030032008

Benito-León, 2003, Mov Disord, 18, 267, 10.1002/mds.10362

Wenning, 2005, Lancet Neurol, 4, 815, 10.1016/S1474-4422(05)70226-X

Barbosa, 2006, Mov Disord, 21, 800, 10.1002/mds.20806

Avorn, 1995, Am J Med, 99, 48, 10.1016/S0002-9343(99)80104-1

Susatia, 2009, Curr Treat Options Neurol, 11, 162, 10.1007/s11940-009-0019-3

Thanvi, 2009, Postgrad Med J, 85, 322, 10.1136/pgmj.2008.073312

Volkow, 1996, J Nucl Med, 37, 554

Stephen, 1984, Lancet, 2, 1082, 10.1016/S0140-6736(84)91516-2

Hardie, 1988, J Neurol Neurosurg Psychiatry, 51, 850, 10.1136/jnnp.51.6.850

Miller, 1989, Arch Intern Med, 149, 2486, 10.1001/archinte.1989.00390110070015

Bedard, 1977, Lancet, 2, 1367, 10.1016/S0140-6736(77)90429-9

Metzer, 1989, Mov Disord, 4, 121, 10.1002/mds.870040203

Liou, 2007, Psychiatry Res, 153, 271, 10.1016/j.psychres.2006.08.007

Inada, 2008, Pharmacogenet Genomics, 18, 317, 10.1097/FPC.0b013e3282f70492

Shanon, 1957, Am J Psychiatry, 114, 556, 10.1176/ajp.114.6.556

Christian, 1958, N Engl J Med, 259, 828, 10.1056/NEJM195810232591708

Janno, 2004, Am J Psychiatry, 161, 160, 10.1176/appi.ajp.161.1.160

Ossowska, 2002, Pol J Pharmacol, 54, 299, 10.1211/0022357021778358

Tarsy, 2002, CNS Drugs, 16, 23, 10.2165/00023210-200216010-00003

Kuroki, 2008, Prog Brain Res, 172, 199, 10.1016/S0079-6123(08)00910-2

Kapur, 2001, Am J Psychiatry, 158, 360, 10.1176/appi.ajp.158.3.360

Stahl, 2001, J Clin Psychiatry, 62, 747, 10.4088/JCP.v62n1001

The Parkinson Study Group, 1999, N Engl J Med, 340, 757, 10.1056/NEJM199903113401003

Schotte, 1996, Psychopharmacology (Berl), 124, 57, 10.1007/BF02245606

Gómez, 2000, J Clin Psychiatry, 61, 335, 10.4088/JCP.v61n0503

Rabey, 2007, Mov Disord, 22, 313, 10.1002/mds.21116

Juncos, 2004, Mov Disord, 19, 29, 10.1002/mds.10620

Wickremaratchi, 2006, Mov Disord, 21, 1538, 10.1002/mds.21025

Sharma, 2006, Int Clin Psychopharmacol, 21, 127, 10.1097/01.yic.0000185025.40656.30

Tonini, 2004, Aliment Pharmacol Ther, 19, 379, 10.1111/j.1365-2036.2004.01867.x

Kenney, 2008, J Clin Pharmacol, 48, 379, 10.1177/0091270007312258

1996, Ceylon Med J, 41, 125

Sethi, 1989, South Med J, 82, 1581, 10.1097/00007611-198912000-00033

Shin, 2009, Mov Disord, 24, 2249, 10.1002/mds.22805

Madej, 1985, Anaesthesia, 40, 202, 10.1111/j.1365-2044.1985.tb10723.x

Sørensen, 1986, Cephalalgia, 6, 7, 10.1046/j.1468-2982.1986.0601007.x

García-Ruiz, 1998, Parkinsonism Relat Disord, 4, 211, 10.1016/S1353-8020(98)00032-7

Martí-Massó, 1998, Mov Disord, 13, 453, 10.1002/mds.870130313

Negrotti, 1997, Mov Disord, 12, 107, 10.1002/mds.870120119

Takada, 1992, Brain Res, 590, 311, 10.1016/0006-8993(92)91112-R

Onofrj, 1998, J Neurol, 245, 794, 10.1007/s004150050288

Easterford, 2004, Neurology, 62, 1435, 10.1212/01.WNL.0000121228.32913.00

Jamora, 2007, Mov Disord, 22, 130, 10.1002/mds.21188

Reches, 1981, Arch Neurol, 38, 471, 10.1001/archneur.1981.00510070105031

Holroyd, 1995, J Geriatr Psychiatry Neurol, 8, 118, 10.1177/089198879500800208

Tinazzi, 2009, J Neurol, 256, 910, 10.1007/s00415-009-5039-0

Hassin-Baer, 2001, J Neural Transm, 108, 1299, 10.1007/s007020100006

Jaber, 1996, Neuropharmacology, 35, 1503, 10.1016/S0028-3908(96)00100-1

Farde, 1992, Arch Gen Psychiatry, 49, 538, 10.1001/archpsyc.1992.01820070032005

Gunne, 1993, Clin Neuropharmacol, 16, 90, 10.1097/00002826-199302000-00012

Gershanik, 1994, Drugs Aging, 5, 127, 10.2165/00002512-199405020-00006

Jiménez-Jiménez, 1996, Parkinsonism Relat Disord, 2, 145, 10.1016/1353-8020(96)00013-2

Davis, 2003, J Nucl Med, 44, 855

Varrone, 2010, J Nucl Med, 51, 1331, 10.2967/jnumed.109.065656

Diaz-Corrales, 2010, Eur J Nucl Med Mol Imaging, 37, 556, 10.1007/s00259-009-1289-4

Lorberboym, 2006, Mov Disord, 21, 510, 10.1002/mds.20748

Tinazzi, 2008, Mov Disord, 23, 1825, 10.1002/mds.22098

Poewe, 2003, Mov Disord, 18, S16, 10.1002/mds.10573

Lavalaye, 2001, Schizophr Res, 47, 59, 10.1016/S0920-9964(00)00023-2

Tolosa, 2003, Mov Disord, 18, S28, 10.1002/mds.10575

Fann, 1976, Am J Psychiatry, 133, 940, 10.1176/ajp.133.8.940

Jankovic, 1995, Clin Neuropharmacol, 18, 197, 10.1097/00002826-199506000-00001

Rajput, 1982, Arch Neurol, 39, 644, 10.1001/archneur.1982.00510220042009

Bishnoi, 2007, Pharmacology, 79, 171, 10.1159/000100924

Tsai, 1998, Am J Psychiatry, 155, 1207, 10.1176/ajp.155.9.1207